Skip to main content

Upcoming Roundup Trial Postponed: Bayer

Upcoming Roundup Trial Postponed: Bayer

Upcoming Roundup Trial Postponed: Bayer

Introduction

On Sunday, Bayer said in a statement, the upcoming trial date October 15, 2019, for Winston v. Monsanto in St. Louis City has been postponed with a court status conference in February 2020.

The Winston lawsuit, involving 14 plaintiffs, was filed in March 2018. The lawsuit is among the pending cases against Bayer claiming that exposure to the company’s glyphosate-based herbicide Roundup, caused them to develop Non-Hodgkin lymphoma, and the manufacturers deceived about the risks associated with it. 

The lawsuit was the latest that had been set for trial in the St. Louis area, involving mediator Ken Feinberg, who is trying to negotiate a settlement between the company and U.S. plaintiffs. Judge Michael Mullen had scheduled the trial date for the lawsuit. According to a court document from the Circuit Court of the City of St. Louis, dated October 4, a status conference to reevaluate the case had been set for February 10.

Currently, Bayer is facing more than 18,400 claims, each involving similar allegations that Roundup causes Non-Hodgkin's lymphoma and other cancers. Roundup lawsuits are consolidated under federal multidistrict litigation (MDL No. 2741; In Re: Roundup Products Liability Litigation) in the Northern District of California, presided by U.S. District Judge Vince Chhabria.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Attorneys Seek Reconsideration of Talc MDL Daubert Ruling

Categories: General

Plaintiffs’ attorneys are urging the U.S. District Judge overseeing the talcum powder lawsuit MDL to reconsider a recent decision for a second round…

Philips resolves DreamStation suits for $1.1B

Categories: Settlements

Dutch medical technology company Philips has finalized a $1.1 billion settlement in the United States to address lawsuits concerning faulty…

FDA OKs Generic OTC Naloxone Spray Approved by FDA

Categories: FDA Related

The FDA has granted approval for Amneal Pharmaceuticals to release a generic 4 mg naloxone hydrochloride nasal spray for over-the-counter (OTC) use, an announcement made in a press release.

Our Legal Drafting Services    
start @ $25 per hour.